Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 337 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

8%

26 trials in Phase 3/4

Results Transparency

10%

4 of 41 completed with results

Key Signals

4 with results100% success

Data Visualizations

Phase Distribution

220Total
Not Applicable (180)
Early P 1 (2)
P 1 (2)
P 2 (10)
P 3 (10)
P 4 (16)

Trial Status

Recruiting129
Not Yet Recruiting118
Completed41
Active Not Recruiting27
Enrolling By Invitation20
Withdrawn2

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 41 completed trials

Clinical Trials (337)

Showing 20 of 20 trials
NCT06995391Not ApplicableRecruitingPrimary

Digitally Rendered Interventions And Knowledge To Limit Ethanol-Associated Atrial Fibrillation Severity

NCT07856472Recruiting

AI-Powered Electrocardiography for Diagnosis and Prognostic Prediction in Cardiovascular Disease (AI-CVD): Multicenter Retrospective Study

NCT07220525Not ApplicableRecruiting

Disrupted Sleep and Concurrent Ectopy or Atrial Fibrillation

NCT07852221RecruitingPrimary

Patient Selection and Long-Term Outcomes of Pace & Ablate Strategy in Atrial Fibrillation

NCT07849777Not ApplicableNot Yet Recruiting

Early Anticoagulation Therapy After Endovascular Treatment for Acute Ischemic Stroke With Atrial Fibrillation

NCT07267949Phase 2RecruitingPrimary

Clinical Phase 2 Trial of AP31969 Versus Placebo for Rhythm Control of Atrial Fibrillation

NCT07840365Phase 3RecruitingPrimary

Optimal Anti-Thrombotic Management Following Percutaneous Left Atrial Appendage Occlusion

NCT07844434Not Yet Recruiting

AI-Based Cardiac Analysis Using 12-Lead and 1-Lead ECG

NCT07626411Phase 3RecruitingPrimary

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation

NCT07820930Not ApplicableNot Yet RecruitingPrimary

A Global Randomized Trial Evaluating the FARAFLEX™ Mapping and Pulsed Field Ablation System With Electrographic Flow Mapping in Patients Undergoing Repeat Ablation for Atrial Fibrillation

NCT07175428Phase 2RecruitingPrimary

Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation

NCT05407415Not ApplicableEnrolling By InvitationPrimary

KardiaMobile ECG Monitoring Effects on Health Care Utilization and Patient Experience With Atrial Fibrillation

NCT07217392Not ApplicableRecruiting

Left Bundle Branch Area Pacing (LBBAP) PMCF Study

NCT07424326Not ApplicableRecruitingPrimary

Extended Ablation Versus Pulmonary Vein Isolation to Treat Persistent Atrial Fibrillation

NCT07187115Not ApplicableActive Not RecruitingPrimary

A Global Study Comparing Pulsed Field Ablation With Electrographic Flow Mapping Versus Posterior Wall Ablation for Persistent Atrial Fibrillation

NCT06656884Active Not RecruitingPrimary

FARAPULSE Workflow Assessment Registry

NCT07827274Not ApplicableNot Yet RecruitingPrimary

Combining Moderate Aerobic Exercise With Inspiratory Muscle Training for Dialysis Patients With Atrial

NCT06606054Not ApplicableNot Yet Recruiting

WSO BEAT STROKE Initiative

NCT07430956Phase 3RecruitingPrimary

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable

NCT07824492Not ApplicableNot Yet RecruitingPrimary

Transcutaneous Regulation for Atrial Prevention in Postoperative Atrial Fibrillation Following OPCAB

Scroll to load more

Research Network

Activity Timeline